A Farnsworth

Summary

Affiliation: Douglass Hanly Moir Pathology
Country: Australia

Publications

  1. ncbi Liquid-based cytology: an Australian experience
    A Farnsworth
    Douglass Hanly Moir Laboratories, NSW, Australia
    Cytopathology 14:48-52. 2003
  2. ncbi Prevention of cervical cancer
    Annabelle Farnsworth
    Douglass Hanly Moir Pathology, 95 Epping Road, North Ryde, NSW 2113, Australia
    Med J Aust 178:653-4. 2003
  3. ncbi Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: an Australian perspective
    Annabelle Farnsworth
    Douglass Hanly Moir Pathology, Sydney, N S W, Australia
    Acta Cytol 55:307-12. 2011
  4. ncbi A randomized crossover trial of PAPNET for primary cervical screening
    Les Irwig
    Screening and Test Evaluation Program, School of Public Health, University of Sydney, Edward Ford Building A27, NSW 2006, Sydney, Australia
    J Clin Epidemiol 57:75-81. 2004
  5. ncbi Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study
    Elizabeth Davey
    Screening and Test Evaluation Program, School of Public Health, University of Sydney, NSW 2006, Australia
    BMJ 335:31. 2007
  6. ncbi Cervical cytology reading times: a comparison between ThinPrep Imager and conventional methods
    Elizabeth Davey
    Screening and Test Evaluation Program, School of Public Health, University of Sydney, Sydney, Australia
    Diagn Cytopathol 35:550-4. 2007
  7. ncbi The changing landscape for cervical screening
    Annabelle Farnsworth
    Med J Aust 189:6-7. 2008

Detail Information

Publications7

  1. ncbi Liquid-based cytology: an Australian experience
    A Farnsworth
    Douglass Hanly Moir Laboratories, NSW, Australia
    Cytopathology 14:48-52. 2003
  2. ncbi Prevention of cervical cancer
    Annabelle Farnsworth
    Douglass Hanly Moir Pathology, 95 Epping Road, North Ryde, NSW 2113, Australia
    Med J Aust 178:653-4. 2003
    ..For a sustainable program, cost-containment issues need to be considered; screening interval, management of screen-detected abnormalities, and new technologies are the critical drivers of cost...
  3. ncbi Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: an Australian perspective
    Annabelle Farnsworth
    Douglass Hanly Moir Pathology, Sydney, N S W, Australia
    Acta Cytol 55:307-12. 2011
    ..Australia therefore faces unique issues and choices in integrating its extensive vaccination program with a successful cervical screening program...
  4. ncbi A randomized crossover trial of PAPNET for primary cervical screening
    Les Irwig
    Screening and Test Evaluation Program, School of Public Health, University of Sydney, Edward Ford Building A27, NSW 2006, Sydney, Australia
    J Clin Epidemiol 57:75-81. 2004
    ..To develop and demonstrate efficient methods to estimate the relative true positive and false positive rates of two cervical screening tests (conventional cytology and PAPNET)...
  5. ncbi Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study
    Elizabeth Davey
    Screening and Test Evaluation Program, School of Public Health, University of Sydney, NSW 2006, Australia
    BMJ 335:31. 2007
    ..To compare the accuracy of liquid based cytology using the computerised ThinPrep Imager with that of manually read conventional cytology...
  6. ncbi Cervical cytology reading times: a comparison between ThinPrep Imager and conventional methods
    Elizabeth Davey
    Screening and Test Evaluation Program, School of Public Health, University of Sydney, Sydney, Australia
    Diagn Cytopathol 35:550-4. 2007
    ..The TPI significantly reduced reading times compared with CC. This reduction was greater amongst slower readers, and was unrelated to experience...
  7. ncbi The changing landscape for cervical screening
    Annabelle Farnsworth
    Med J Aust 189:6-7. 2008